Markus F. Scheerer

机构：Helmholtz Munich, Bayer (Germany)

发表论文 79 篇 · 总被引 2089 次 · h-index 25

代表论文

• Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (2025 · New England Journal of Medicine · 被引 253)
• Finerenone and Kidney Outcomes in Patients With Heart Failure (2024 · Journal of the American College of Cardiology · 被引 76)
• Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure (2024 · Circulation · 被引 64)
• Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial (2023 · Diabetes Research and Clinical Practice · 被引 62)
• Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction (2024 · Journal of the American College of Cardiology · 被引 47)
• Finerenone in Type 1 Diabetes and Chronic Kidney Disease (2026 · New England Journal of Medicine · 被引 27)